We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOFI icon
1476
CALL
SoFi Technologies
SOFI
$23.1B
– –
-109
Closed -$1K
SONO icon
1477
Sonos
SONO
$1.78B
$0 ﹤0.01%
7
-326
-98% -$4.18K
SONY icon
1478
Sony
SONY
$137B
– –
-41,000
Closed -$1.07M
SOUN icon
1479
CALL
SoundHound AI
SOUN
$3.28B
– –
-210
Closed -$2K
SPTN
1480
DELISTED
SpartanNash
SPTN
– –
-5,000
Closed -$132K
SRAD icon
1481
Sportradar
SRAD
$3.88B
– –
-13
Closed –
SRPT icon
1482
Sarepta Therapeutics
SRPT
$1.91B
$0 ﹤0.01%
14
-254
-95% -$4.53K
ST icon
1483
Sensata Technologies
ST
$6.81B
$0 ﹤0.01%
+14
New +$442
STM icon
1484
STMicroelectronics
STM
$50.6B
– –
-134
Closed -$3.75K
SWTX
1485
CALL
DELISTED
SpringWorks Therapeutics
SWTX
– –
-49
Closed -$2K
SYM icon
1486
Symbotic
SYM
$5.49B
$0 ﹤0.01%
+14
New +$708
TEAM icon
1487
CALL
Atlassian
TEAM
$38.6B
– –
-12
Closed -$2K
TENB icon
1488
Tenable Holdings
TENB
$4.08B
– –
-401
Closed -$13K
TFC icon
1489
Truist Financial
TFC
$63.9B
$0 ﹤0.01%
+14
New +$631
TGB
1490
Trekor Metals
TGB
$3.3B
$0 ﹤0.01%
+14
New +$48
TGT icon
1491
CALL
Target
TGT
$69.2B
– –
-27
Closed -$2K
THRD
1492
DELISTED
Third Harmonic Bio
THRD
– –
-100,100
Closed -$543K
THTX
1493
DELISTED
Theratechnologies
THTX
– –
-1,400
Closed -$3K
TIXT
1494
DELISTED
TELUS International
TIXT
– –
-50,000
Closed -$181K
TJX icon
1495
TJX Companies
TJX
$171B
– –
-100
Closed -$12K
TKO icon
1496
TKO Group
TKO
$14.1B
– –
-33
Closed -$6K
TLS icon
1497
Telos
TLS
$324M
– –
-17,020
Closed -$53K
TOST icon
1498
CALL
Toast
TOST
$19.7B
– –
-45
Closed -$1K
TOST icon
1499
Toast
TOST
$19.7B
– –
-10,013
Closed -$443K
TPG icon
1500
TPG
TPG
$8.03B
– –
-67
Closed -$3K
58 59
60
61 62

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.